Introduction
============

Chronic obstructive pulmonary disease (COPD) is characterized by limitations in the lung airflow with serious public health issues.[@b1-copd-11-2609] Ventilatory limitation (deficiency) is the first cause of breathlessness and exercise intolerance (incapacity) among these patients impacts their physical activities of daily living, thus leading to social disadvantage.[@b2-copd-11-2609] Hence, the evaluation of exercise tolerance and the functional capacity of the patients lie within the assessment of disease progression. This evaluation can be done by simple field tests that require minimal technical equipment and could be performed in an environment that is comfortable for the patients. With the availability of various tests such as the 6-minute walk test (6MWT), the incremental shuttle walk test, the endurance shuttle walk test, the stair climbing test, the step test, and the sit-to-stand (STS) test or chair rise test, choosing the right test for these patients could be tricky.[@b3-copd-11-2609]--[@b8-copd-11-2609] The STS test has been developed for different chronic diseases and elderly people, since the gesture of getting up from a chair is an essential activity of daily living. This ability to stand up from a chair is an important component of maintaining independence among the elderly people, as this movement depends on stability and balance.[@b9-copd-11-2609] Hence, this test is accepted as an indicator of functional status among the elderly people but scarcity of data prevails for the COPD population.[@b10-copd-11-2609] Being a validated measure of the functional outcome in COPD patient, the STS test could also be considered a surrogate to the walking test.[@b7-copd-11-2609],[@b11-copd-11-2609] Therefore, we aimed at evaluating the 1-minute STS test minimal important difference (MID) among COPD patients undergoing a pulmonary rehabilitation (PR).

Materials and methods
=====================

Subjects
--------

Patients were included in this study if they fulfilled the following criteria: a diagnosis of COPD according to the Global initiative for COPD (GOLD) recommendations, having completed a PR and joined the cohort RéhaEffort from the Institut de Recherche en Santé Respiratoire des Pays de la Loire (IRSR) or the Centre Hospitalier des Pays de Morlaix.[@b12-copd-11-2609] Forty-eight consecutive COPD patients were included (30 males), aged 64.5±9.8 years and mean forced expiratory volume in 1 second (FEV~1~) 52.3%±16.1%. The patients were recruited in four different centers in two cities: the Lung Function Department, the Pulmonary Rehabilitation Department of the Nantes University Hospital, the Tourmaline Medical Centre in Nantes, the Pulmonology Department of the Angers University Hospital, and the Centre Hospitalier des Pays de Morlaix, Pulmonary Rehabilitation Unit, France. The study was conducted by the RéhaEffort cohort group from the IRSR. Approval was obtained from the University of Angers ethics committee and the Comité Consultatif sur le Traitement de l'Information en matière de Recherche dans le domaine de la Santé (07.207 bis). All patients included in the RéhaEffort cohort provided their written informed consent. For the patients from the Centre Hospitalier des Pays de Morlaix, they signed a written informed consent form in accordance with the Declaration of Helsinki and the current guidelines for Clinical Good Practice after approval by the Institutional Medical Ethics Committees (BE403201317621 -- 2009/17 -- 07 207 bis).

Study design
------------

All the patients went through a complete outpatient visit in our institutions to assess individual deficiency, incapacity, and social disadvantage in detail as recommended.[@b13-copd-11-2609] The pulmonary function tests were obtained using a volume/pressure body plethysmograph (MasterScreen^®^ Body, Becton, Dickinson and Company, Franklin Lakes, NJ, USA) according to the European Respiratory Society and American Thoracic Society task force.[@b14-copd-11-2609],[@b15-copd-11-2609] The European Coal and Steel Community reference values were used.[@b16-copd-11-2609] All patients performed a cardiopulmonary exercise test that was obtained using a progressive 10W incremental test on an electromagnetically braked cycle ergometer up to exhaustion as recommended.[@b17-copd-11-2609] Field exercise and muscle strength tests included a 6MWT and a measure of the quadriceps maximal voluntary contraction (QMVC). The evaluation of quality of life was done using the St George's Respiratory Questionnaire and the Hospital Anxiety and Depression questionnaire.

One-minute STS test
-------------------

The 1-minute STS test was performed with a chair of standard height of 46 cm without arm rests. The patient was ensured to be seated upright on the chair positioned against a wall. The patient sat with the knees and hips flexed to 90°, feet placed flat on the floor hip-width apart, and the hands placed on the hips. Every get up from one's chair was validated to check if complete sit-to-stand-to-sit sequence was achieved. The patient was given the following instructions: "The purpose of the test is to assess your exercise capacity and leg muscle strength. The movement required is to get up from this chair with the legs straight and sit back continuing the repetitions as fast as possible within one minute. I will give you the countdown '3, 2, 1 Go' as an indication to start and also I will tell you when we are at the 15 remaining seconds. If required, you can make a break and resume the test as soon as possible."

The number of repetitions was measured using a dedicated actimeter conceived for this purpose from Bluenight^®^ (SleepInnov Technology, Moirans, France), controlled by the video and expressed in percentage of reference values.[@b18-copd-11-2609] The Modified Borg Scale was used to assess dyspnea and fatigue. The test was performed at baseline and repeated at the end of PR.

Six-minute walk test
--------------------

The 6MWT was conducted in a 30 m long corridor following the recommendations.[@b19-copd-11-2609],[@b20-copd-11-2609] The test was performed using the Bluenight^®^ oximeter (SleepInnov Technology) to measure the heart rate and oxygen saturation during the procedure. The test was repeated twice, once at the beginning and once at the end of PR, with the best distance recorded.

Quadriceps maximum voluntary contraction
----------------------------------------

The evaluation of the QMVC was performed by measuring the maximal voluntary isometric contraction using the handheld dynamometer microFET2™ (Hoggan Scientific, LLC, Salt Lake City, UT, USA). To prevent any operator bias, the device was fixed on the leg of the table, with the patient comfortably seated using a high-density corner cushion to maintain their knees at 90°, as recommended.[@b21-copd-11-2609] At least three measures were registered for each leg (additional measures were taken if the third was better than the previous ones -- suggesting a learning effect -- up to a lower result, which completed the session). The highest value was expressed in Newton and used in the analysis.[@b22-copd-11-2609] This measure was reproduced at the end of PR.

Statistical analysis
--------------------

All results were presented as mean ± standard deviation (SD) for the quantitative variables. The qualitative variables were expressed in percentages. Statistical analyses were performed using SPSS 17.0 statistical software (SPSS Inc., Chicago, IL, USA). The determination of the dependent variable, the 1-minute STS repetitions at baseline, and other independent variables were made using the univariate linear regression analysis. These included anthropometric parameters, the data of the combined COPD assessment A, B, C, and D categories, the Charlson and body mass index, airflow obstruction, dyspnea and exercise capacity index pulmonary function parameters (from the forced expiratory maneuver, plethysmography, and respiratory muscle strength), cardiopulmonary exercise tests parameters, 6MWT, and QMVC parameters. This was followed by a multivariate analysis, combining the most relevant independent variables from the univariate analysis that showed at least a tendency with the 1-minute STS repetitions, ie, a *P*-value \<0.2. Only independent variables, which increased consistently the explained variance (R^2^ coefficient of determination) of the 1-minute STS repetitions, were used in the final model.

The variables that significantly changed from baseline to the end of the PR were identified using a paired *t*-test in case of normality of the distribution or the Wilcoxon test if not.

The analysis of the MID was based on the use of distribution-based methods, using the effect size method (1-minute STS repetitions~\[end-baseline\]~/SD~baseline~), the standardized response mean method (1-minute STS repetitions~\[end-baseline\]~/SD~\[end-baseline\]~), the SD method (0.5× SD of 1-minute STS repetitions at baseline) or the standard error of measurement method (SD of 1-minute STS repetitions at baseline × √\[1-{test--retest reliability}\]). Based on personal data of our team, not yet published, we found the test--retest reliability of the 1-minute STS test to be 0.906. For anchor-based estimation of the MID, we used the change from baseline variables that correlated with the change in 1-minute STS repetitions from baseline to the end with a correlation coefficient of at least 0.3 and a *P*-value \<0.05 as recommended.[@b23-copd-11-2609] Then, we used the sensitivity- and specificity-based approach with receiver operating characteristic curves to determine the best cutoff for the change in 1-minute STS repetitions with the established MID of 30 m for the 6MWT, according to the recommendations.[@b19-copd-11-2609],[@b20-copd-11-2609] A *P*-value of \<0.05 was considered significant.

Results
=======

The characteristics of the subjects included in the study are given in [Table 1](#t1-copd-11-2609){ref-type="table"}. Using the GOLD spirometric classification, the repartition was 5% in GOLD 1, 49% in GOLD 2, 28% in GOLD 3, and 18% in GOLD 4. Using the combined COPD assessment A, B, C, and D categories, the repartition was 9% in group A, 30% in group B, 3% in group C, and 58% in group D.[@b12-copd-11-2609]

Determinants of 1-minute STS repetitions at baseline
----------------------------------------------------

The main parameters linked with 1-minute STS repetitions at baseline in the univariate analysis were as follows: 6-minute walk distance (6MWD) (*r*=0.574; *P*\<10^−3^), age (*r*=−0.453; *P*=0.001), patients on long-term oxygen treatment (*r*=−0.454; *P*=0.017), and QMVC (*r*=0.424; *P*=0.031). The height was weakly (but not significantly) and negatively associated with the number of repetitions (*r*=−0.197; *P*=0.185). There were no significant results with variables from pulmonary function tests (notably lung hyperinflation parameters) and cardiopulmonary exercise tests. The best prediction model in the multivariate analysis was obtained with a combination of 6MWD, height, and QMVC, without any improvement of the model after adjustment for age and sex. The explained variance of 1-minute STS repetitions from the determination coefficient (*R*^2^) was 75.8% ([Table 2](#t2-copd-11-2609){ref-type="table"}).

Responsiveness to PR
--------------------

The change in the parameters measured during the 1-minute STS test at baseline and at the end of the PR are listed in [Table 3](#t3-copd-11-2609){ref-type="table"} and compared with the main parameters obtained from the 6MWT and the QMVC in [Table 4](#t4-copd-11-2609){ref-type="table"}. The change in 1-minute STS repetitions was correlated with the change in 6MWD (*r*=0.428; *P*=0.006) and QMVC (*r*=0.572; *P*=0.004) ([Figure 1](#f1-copd-11-2609){ref-type="fig"}).

Determination of the minimal important difference
-------------------------------------------------

Using the distribution-based methods, the MID calculated for the change in the number of repetitions was 3.1 using the SD, 1.9 using the standard error of measurement, with an effect size of 0.6. For the anchor-based method, we use the MID of 30 m from the 6MWT as anchor. The receiver operating characteristic curve identified the point between 2.5 and 3.5 with the best sensitivity (80% and 64%, respectively) and specificity (60% and 67% respectively) with an area under the curve of 0.716 ([Figure 2](#f2-copd-11-2609){ref-type="fig"}).

Determinants of an improvement of 1-minute STS repetitions between baseline and the end of PR
---------------------------------------------------------------------------------------------

Only two parameters were significantly associated with the improvement of 1-minute STS repetitions between baseline and end of PR. The univariate analysis identified the change in the distance obtained from the 6MWT (*r*=0.496; *P*=0.001) and the change in the QMVC (*r*=0.503; *P*=0.015), with an explained variance (*R*^2^) of 24.6% and 25.3%, respectively. The combination of both parameters in the multivariate analysis produced a model in which the explained variance increased to 43.9% (*r*=0.663; *P*=0.003), with the following equation: Change in 1-minute STS repetitions = 0.041× (change in 6MWD) + 0.049 × (change in QMVC) + 1.052 in which both parameters remained significant (0.018 and 0.047, respectively).

Discussion
==========

The results of this study demonstrate the utility of the 1-minute STS test in the assessment of COPD patients undergoing PR. Its ability to detect a change in exercise tolerance is similar to the 6MWT. The change in the number of repetitions also correlated with the change in the distance from the 6MWT as well as the change in QMVC, which makes this tool a valuable test to assess lower limb strength and the impact on walking capacity. Using different methods to determine the MID of the 1-minute STS test, a change of at least three repetitions provides a good agreement in comparison to the 30 m improvement in 6MWD.

The STS test was first introduced as a measure of lower limb strength and remains an important marker of an independent lifestyle.[@b24-copd-11-2609] Since then, various studies have been conducted with different modalities of this test. Ozalevli et al was one of the first to compare the 1-minute STS test with the 6MWT, and the results demonstrated a good correlation (*r*=0.75; *P*\<0.001) among these tests.[@b7-copd-11-2609] Similar to the 6MWT, the 1-minute STS test was able to determine the functional status correctly.[@b7-copd-11-2609] Their study presented the 1-minute STS test as an alternative to the 6MWT in COPD patients. Unlike the 6MWT, where a practice test is recommended, the STS test seems less prone to the learning effect.[@b19-copd-11-2609],[@b20-copd-11-2609] Recent data show that the number of repetitions a patient is able to do during the 1-minute STS correlated with the level of physical activity, which makes it a good surrogate of physical activity.[@b25-copd-11-2609] This was also reported by van Gestel et al who showed that the number of steps taken per day related to the number of repetitions in the 1-minute STS test among COPD patients.[@b26-copd-11-2609] The 1-minute STS test is then a good surrogate of the level of physical activity achieved by a patient in his daily life. In this study, we not only found a correlation with age but also a relation with the patient's height, which underlines the influence of chair height on lower limb mechanics during rising.[@b27-copd-11-2609]

While the perception of the effort by the patient in terms of dyspnea and fatigue was similar in the 1-minute STS test and 6MWT, the physiological responses measured by the pulse oxygen saturation and heart rate were less important in the 1-minute STS test. This test therefore seems more appropriate for the evaluation of the leg capacity apart from the ventilatory limitations. Consequently, it provides relevant information about the quality of the biomechanical response in terms of postural control and lower limb muscle strength. Because the ventilatory limitations may be more limited than balance in COPD patients, it is not surprising to find a good correlation between the 1-minute STS test and the quadriceps strength as it was reported by others using the 30-seconds or 1-minute STS test.[@b28-copd-11-2609],[@b29-copd-11-2609] A more recent modality of the STS test in 3 minutes presented by Aguilaniu et al shows a good interchangeability of the physiological characteristics among the 6MWT and the STS test.[@b30-copd-11-2609] But this proof of concept study still suffers from weaknesses due to a more complex modality compared with previous STS tests. Moreover, there is no confirmation by other teams or studies of the advantage of such modality, which limits its use in practice.

More interesting is the ability of the 1-minute STS test to detect a change in the functional status of the subjects. In the whole group in average, there was an improvement in the number of repetitions and a reduction in the perception of dyspnea at the end of PR. The differences were not significant for the heart rate and pulse oxygen saturation, which is probably related to the short duration of the test even if it is perceived as a maximal task by the patient. It provides additional information that cannot be compared to more standardized incremental exercise tests, such as the incremental shuttle walk test or cardiopulmonary exercise test. While STS tests explored the balance quality and the efficiency of the biomechanical properties of lower limbs, the incremental exercise tests explored the maximal cardiorespiratory and metabolic capacities of the patient. The lack of these abilities contribute to the worsening of a sedentary lifestyle by patients, which is the hallmark of disability in chronic diseases of the cardiac, respiratory, locomotor, and metabolic systems.[@b1-copd-11-2609] The study conducted by Jones et al[@b11-copd-11-2609] showed that the simple five-repetition STS test was responsive to PR, as Panton et al previously demonstrated a significant increase in the number of repetitions in the 1-minute STS test among 17 COPD subjects after an aerobic-based training program.[@b31-copd-11-2609] As the improvement in the 1-minute STS test presented in our study matched the improvement in 6MWT and QMVC, we were able to estimate an MID between 1.9 and 3.5 with a consistent effect size using different distribution and anchor-based approaches. An operational target of at least 2.5, ie, three more repetitions, represents an acceptable and conservative estimate. We opted for an MID of 30 m for the 6MWD, which corresponds to the last European Respiratory Society and American Thoracic Society task force recommendation in chronic respiratory disease.[@b19-copd-11-2609],[@b20-copd-11-2609] However, there could be some variability in the number of repetitions depending on the distance chosen as the MID, ie, a higher number of repetitions for a distance of 33 m and lower using 25 m.

Limitations
===========

This study entailed some limitations partly due to the small number of subjects included. However, the multicenter approach ensures that the significant results obtained provide a robust and realistic picture of the heterogeneity of COPD patients in the daily practice of PR. In another way, some results did not reach the significance probably because of low statistical power that should be confirmed by larger studies. It is particularly important to clarify some issues about the standardization of the test, notably the impact of adjusting the height of the seat to guarantee an optimal position for all patients.[@b32-copd-11-2609],[@b33-copd-11-2609] Although the 1-minute STS test remains a good surrogate of lower limb strength, this property could be biased in overweight patients in whom sitting up from a chair represents a higher energy expenditure compared to normal weight patients. But this should be confirmed in further studies, since the weight was not found to be a determinant at least in the five-repetition STS.[@b34-copd-11-2609] These limitations are partially overcome by the use of reference values for 1-minute STS test that allow intergroup comparisons.[@b18-copd-11-2609] But one of the most important result is the sensitivity to change the 1-minute STS test to objectively assess the improvement of a given patient after PR.

Conclusion
==========

In conclusion, this study shows that the 1-minute STS test is a simple and sensitive test that is capable of depicting physical improvement after PR. An MID of 3 represents a good target to consider for assessing the benefit gained by patients after an intervention of physical training.
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![Association between change in 1-minute STS test and change in (**A**) 6-minute walk distance (6MWD) and (**B**) quadriceps maximal voluntary contraction (QMVC) with pulmonary rehabilitation.\
**Note:** (**A** and **B**) The black dotted line is the linear regression of the relation between the two variables.\
**Abbreviations:** 6MWD, 6-minute walk distance; QMVC, quadriceps maximal voluntary contraction; STS, sit-to-stand.](copd-11-2609Fig1){#f1-copd-11-2609}

![Receiver operating characteristic curve for the identification of the minimal important difference of the 1-minute STS test using a 30 m improvement in 6-minute walk test as anchor.\
**Abbreviations:** STS, sit-to-stand; AUC, area under curve.](copd-11-2609Fig2){#f2-copd-11-2609}

###### 

Baseline characteristics of the patients

  -------------------------------------------------------------------------- -------------
  Male/female, n                                                             30/18
  Age, year                                                                  64±9.8
  BMI, kg/m^2^                                                               26.4±7
  Smoking, pack-year                                                         44.7±21.8
  Dyspnea, mMRC                                                              2.2±0.7
  Charlson index                                                             3.5±1.7
  Lung function:                                                             
  \* FEV~1~, % predicted                                                     52.3±16.9
  \* FVC, % predicted                                                        77.6±19.6
  \* FEV~1~/FVC                                                              54.4±12.5
  \* RV/TLC, % predicted                                                     135.4±27.5
  \* MIP, % predicted[\#](#tfn2-copd-11-2609){ref-type="table-fn"}           79.8±20.2
  Exercise testing:                                                          
  \* 6MWD, m                                                                 387.6±111
  \* 6MWD, %[\#](#tfn2-copd-11-2609){ref-type="table-fn"}                    64±38
  \* 6MWT desaturation, n (%)                                                20 (42)
  \* QMVC, %[\#](#tfn2-copd-11-2609){ref-type="table-fn"}                    72.5±21.8
  \* Peak O~2~ consumption, ml/min/kg                                        13.8±3
  \* Peak O~2~ consumption, %[\#](#tfn2-copd-11-2609){ref-type="table-fn"}   61.2±15.3
  SGRQ total score                                                           55.1 ± 15.1
  HAD total score                                                            16±6.8
  BODE index                                                                 3.1±1.5
  -------------------------------------------------------------------------- -------------

**Notes:** Data are presented as mean ± SD unless otherwise indicated. Post-bronchodilator results are provided in percentage of predicted value.

Predicted values are from Uldry et al[@b35-copd-11-2609] for MIP, from Troosters et al[@b37-copd-11-2609] for the 6MWD, from Hogrel et al[@b38-copd-11-2609] for QMVC and from Hansen et al[@b39-copd-11-2609] for Peak O~2~ consumption. 6MWT desaturation, fall of at least 4% of the SpO~2~, and post-test SpO~2~ \<90% according to Wedzicha et al[@b36-copd-11-2609].

**Abbreviations:** BMI, body mass index; BODE, body mass index, airflow obstruction, dyspnoea and exercise capacity index; FEV~1~, forced expiratory volume in 1s; FVC, forced vital capacity; HAD, hospital anxiety depression; MIP, maximal inspiratory pressure; mMRC, modified medical research council scale; 6MWD, 6-minute walk distance; QMVC, quadriceps maximum voluntary contraction; RV/TLC, residual volume/total lung capacity; SGRQ, saint george respiratory questionnaire.

###### 

Main determinants of 1-minute STS repetitions at baseline (multivariate analysis)

  Variables      *b*      Correlation coefficient (*r*)   *P*-value
  -------------- -------- ------------------------------- -----------
  6MWD, m        0.038    0.834                           \<10^−3^
  Height, cm     −0.438   −0.532                          \<10^−3^
  QMVC, Newton   0.016    0.236                           0.065
  *b0*           74.254                                   

**Notes:** The predicted equation is based on a linear regression analysis with the following form: 1-minute STS repetitions = *b0* + *(b ×* 6MWD) + *(b ×* height) + *(b ×* QMVC) =74.254 + 0.038× 6MWD −0.438× height + 0.016 × QMVC).

**Abbreviations:** 6MWD, 6-minute walk distance; QMVC, quadriceps maximal voluntary contraction; STS, sit-to-stand.

###### 

Change of the parameters measured during 1-minute STS test at baseline and at the end of PR

                             Baseline     End          *P*-value
  -------------------------- ------------ ------------ -----------
  1-minute STS repetitions   19.2±6.1     23.0±7.7     \<10^−3^
  Dyspnea, Borg scale        4.9±2.1      4.0± 1.7     0.025
  HR, beats/min              101.3±15.7   101.9±15.3   0.705
  SpO~2~, %                  91.6±3.9     91.2±4.4     0.902

**Notes:** The test was performed at the inclusion (Baseline) and at the end of the PR (End). All the variables were measured at the end of each test (1 minute). Data presented as mean ± standard deviation.

**Abbreviations:** 6MWD, 6-minute walk distance; HR, heart rate; PR, pulmonary rehabilitation; QMVC, quadriceps maximal voluntary contraction; SpO~2~, minimal pulse oxygen saturation percentage measured at the end of the test; STS, sit-to-stand.

###### 

Comparisons between 1-minute STS repetitions, 6MWD and QMVC at baseline and the end of the PR

                             Baseline     Change from baseline (absolute value)   Change from baseline (% baseline value)   *P*-value
  -------------------------- ------------ --------------------------------------- ----------------------------------------- -----------
  1-minute STS repetitions   19.2±6.1     3.8±4.2                                 23±28                                     \<10^−3^
  6MWD, m                    387.6±111    45.3±47.7                               15±17                                     \<10^−3^
  QMVC, Newton               244.6±83.7   27.4±39.5                               14±21                                     0.003

**Notes:** The tests were performed at the inclusion (Baseline) and at the end of the PR. Data presented as mean ± standard deviation.

**Abbreviations:** 6MWD, 6-minute walk distance; QMVC, quadriceps maximal voluntary contraction; STS, sit-to-stand.
